title: HMG-CoA reductase inhibitors: an exciting development in the treatment of hyperlipoproteinemia.
authors.affiliation: Preclinical Research Department, Sandoz Research Institute, East Hanover, New Jersey 07936.
authors.forename: F G
authors.initials: FG
authors.lastname: Kathawala
mesh_terms: D000818:Animals; D005229:Fatty Acids, Monounsaturated / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics; D000077340:Fluvastatin; D006801:Humans; D006904:Hydroxymethylglutaryl-CoA Synthase / Q000037:antagonists & inhibitors*; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D007211:Indoles / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics; D008074:Lipoproteins / Q000097:blood
chemical_list: D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D008074:Lipoproteins; D000077340:Fluvastatin; D006904:Hydroxymethylglutaryl-CoA Synthase